17.04.2018
- For the global specialty chemicals sector, the past two years have been among the most exciting of the young millennium. Many mergers and acquisitions were in the spotlight in 2017...
13.04.2018
- French drugmaker Sanofi plans to build a new state-of-the-art vaccine manufacturing facility at the Canadian headquarters of its vaccines global business unit Sanofi Pasteur in...
04.04.2018
- Japanese drugmaker Takeda has announced that it is considering buying Ireland-domiciled drugmaker Shire, although it stressed that the offer was “at a preliminary and exploratory...
16.03.2018
- ABL Europe has successfully increased and brought online new viral vector manufacturing capacity at its European facility in Strasbourg. A subsidiary of ABL Inc., ABL Europe has...
15.03.2018
- Hamburg, Germany-based drug development specialist Evotec and French drugmaker Sanofi have entered into exclusive negotiations calling for Evotec to accelerate infectious disease...
02.03.2018
- Sanofi has received all the necessary regulatory approvals for its planned €3.9 billion takeover of Belgian biotech Ablynx. The deal was announced on Jan. 29. The next step is to...
27.02.2018
- Contract development and manufacturing organization (CDMO) Lonza said it exceeded its full-year 2017 guidance. The company reported sales of CHF 5.1 billion. Having closed the...
04.02.2018
- Lending fuel to the ongoing controversy in the Philippines over the possible side effects of Sanofi Pasteur 's Dengue vaccine Dengvaxia, an initial report by the Philippine General...
30.01.2018
- Sanofi is to acquire Belgium biopharma Ablynx in a deal valued at around €3.9 billion. The announcement comes just days after the French drugmaker announced its intention to buy US...
24.01.2018
- Sanofi is boosting its presence in blood disorders through the acquisition of Bioverativ, the former hemophilia business of major US biotech Biogen, which was spun out in February...
